EXICURE, INC. Net Income (Loss) Available to Common Stockholders, Basic
EXICURE, INC. (XCUR) reported Net Income (Loss) Available to Common Stockholders, Basic of -$1.83 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-29.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-05-29
- EXICURE, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$1.83M, a 160.73% decline year-over-year.
- EXICURE, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-03-31 was $3.01M.
- EXICURE, INC. net income (loss) available to common stockholders, basic for fiscal 2025 was -$4.95M.
- EXICURE, INC. net income (loss) available to common stockholders, basic for fiscal 2024 was -$9.70M.
- EXICURE, INC. net income (loss) available to common stockholders, basic for fiscal 2023 was -$16.91M.
- EXICURE, INC. net income (loss) available to common stockholders, basic for fiscal 2022 was -$2.58M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|
| 2026-03-31 | -$1.83M 10-Q · filed 2026-05-29 | |
| 2025-12-31 | -$4.95M 10-K · filed 2026-03-25 | |
| 2025-03-31 | $3.01M 10-Q · filed 2026-05-29 | |
| 2024-12-31 | -$9.70M 10-K · filed 2026-03-25 | |
| 2023-12-31 | -$16.91M 10-K · filed 2025-03-18 | |
| 2022-12-31 | -$2.58M 10-K · filed 2024-06-06 | |
| 2021-12-31 | -$64.10M 10-K · filed 2023-03-27 | |
| 2020-12-31 | -$24.67M 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |